Sign In
Buy MRNA
$59.81
+0.640 (+1.08%)
At Close: Aug 10, 2026
mRNA Vaccines Market Trends and Competition Analysis 2025-2030: Revenues are Projected to Nearly Double, Growing by ~$8 Billion
05:20am, Tuesday, 18'th Mar 2025
Dublin, March 18, 2025 (GLOBE NEWSWIRE) -- The "mRNA Vaccines Market by Technology Type, Route of Administration, Manufacturing Process, Vaccine Classification, Application Areas, End-User, Distributi
Moderna (MRNA) Advances But Underperforms Market: Key Facts
06:55pm, Monday, 17'th Mar 2025
In the latest trading session, Moderna (MRNA) closed at $34.71, marking a +0.26% move from the previous day.
Down 93%, Is It Finally Time to Buy Moderna?
04:38am, Saturday, 15'th Mar 2025
As we near the five-year anniversary of the COVID-19 pandemic, it's a good time to revisit the drugmaker stock that was top of mind back then. A few years ago, Moderna (MRNA 0.93%) stock soared on the
Moderna (MRNA) Presents at Barclays 27th Annual Global Healthcare Conference (Transcript)
03:59pm, Tuesday, 11'th Mar 2025
Moderna (NASDAQ:MRNA ) Barclays 27th Annual Global Healthcare Conference March 11, 2025 1:30 PM ET Company Participants Rose Loughlin - EVP of Research Lavina Talukdar - SVP, Head of IR Conference Cal
Insiders Are Loading Up on These 4 Biotech Stocks Now
08:45am, Tuesday, 11'th Mar 2025
Things are heating up in the biotechnology space, with a flurry of recent initial public offerings and some notable insider purchases of the past week or so.
Why Moderna Stock Has Surged 20% This Week Despite Mixed News
11:58am, Friday, 07'th Mar 2025
Moderna stock has surged more than 20% this week after regulatory filings showed several executives bought shares on the open market. The post Why Moderna Stock Has Surged 20% This Week Despite Mixed
The Zacks Analyst Blog Jazz Pharmaceuticals, Chimerix, Moderna, GSK and Regeneron Pharmaceuticals
04:01am, Friday, 07'th Mar 2025
Jazz Pharmaceuticals, Chimerix, Moderna, GSK and Regeneron Pharmaceuticals are included in this Analyst Blog.
Moderna: Insider Buy Signal
04:11pm, Thursday, 06'th Mar 2025
Insider buying signals a market shift for Moderna, Inc. after years of relentless sales, with CEO Stephane Bancel purchasing MRNA shares due to perceived undervaluation. Moderna cut revenue guidance f
Biotech Stocks Roundup: CMRX Up on JAZZ Bid, MRNA Up on Updates & More
04:00pm, Thursday, 06'th Mar 2025
CMRX and JAZZ are in the spotlight this week following an acquisition agreement.
Here's Why Moderna Stock Soared 16% on Wednesday
10:15am, Thursday, 06'th Mar 2025
The surge in MRNA stock comes after some SEC filings show that company insiders bought shares worth $6 million.
Everest Medicines Announces First Patient Dosed with EVM16, Its First Internally Developed Personalized mRNA Cancer Vaccine
03:30am, Thursday, 06'th Mar 2025
The first patient has been dosed with EVM16 at Peking University Cancer Hospital, marking a major milestone as Everest's proprietary AI-based tumor neoantigen prediction algorithm and clinically valid
Why Moderna Stock Zoomed Nearly 16% Higher on Wednesday
05:59pm, Wednesday, 05'th Mar 2025
A big legal victory across the Atlantic Ocean was the news propelling Moderna (MRNA 15.94%) stock to a significant price surge on Hump Day. The win by the company, best known as the producer of the Sp
S&P 500 Gains and Losses Today: Moderna Stock Pops as Execs Buy Shares, Express Cancer Vaccine Optimism
05:15pm, Wednesday, 05'th Mar 2025
Major U.S. equities indexes fluctuated on Wednesday before gaining momentum in the afternoon to close the session higher.
Moderna, Inc. (MRNA) TD Cowen 45th Annual Health Care Conference
12:57pm, Wednesday, 05'th Mar 2025
Moderna, Inc. (NASDAQ:MRNA ) TD Cowen 45th Annual Health Care Conference March 5, 2025 9:10 AM ET Corporate Participants Stephen Hoge - President Conference Call Participants Tyler Van Buren - TD Cowe
Moderna shares jump on insider stock purchases
11:27am, Wednesday, 05'th Mar 2025
Moderna Inc (NASDAQ:MRNA, ETR:0QF) shares moved higher after it was disclosed the company insiders have purchased $6 million in shares. According to filings with the Securities and Exchange Commission
